vinorelbine
Selected indexed studies
- Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer. (J Clin Oncol, 2020) [PMID:32407216]
- Vinorelbine in cancer therapy. (Curr Drug Targets, 2012) [PMID:22594474]
- Vinorelbine: a novel vinca alkaloid. (Am J Health Syst Pharm, 1995) [PMID:7656116]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer. (2020) pubmed
- Vinorelbine in cancer therapy. (2012) pubmed
- Vinorelbine: a novel vinca alkaloid. (1995) pubmed
- Vinorelbine for non-small cell lung cancer. (2010) pubmed
- Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review. (2018) pubmed
- Vinorelbine. A review of its antitumour activity in lung cancer. (1992) pubmed
- Vinorelbine's anti-tumor actions may depend on the mitotic apoptosis, autophagy and inflammation: hypotheses with implications for chemo-immunotherapy of advanced cancers and pediatric gliomas. (2018) pubmed
- Clinical pharmacokinetics of vinorelbine. (1996) pubmed
- Oral vinorelbine in the treatment of non-small-cell lung cancer. (2014) pubmed
- Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy. (1994) pubmed